Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,573,672
+$9,418,432 QoQ
Shares Held
2,854,205
+6.5% QoQ
Ownership
1.69%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. VIR ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in VIR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,573,672 | 2,854,205 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,155,240 | 2,679,145 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $15,354,859 | 2,689,118 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $8,233,793 | 1,633,690 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $9,229,753 | 1,424,345 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,248,732 | 1,123,806 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $9,264,519 | 1,236,919 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $18,896,583 | 2,123,212 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $23,696,700 | 2,339,260 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $21,390,364 | 2,126,279 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $13,000,083 | 1,387,416 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $16,918,974 | 689,726 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,935,421 | 598,858 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $29,810,822 | 1,177,828 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,088,282 | 1,145,658 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,542,589 | 1,081,374 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $15,217,956 | 591,678 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $51,545,903 | 1,231,094 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,291,685 | 144,570 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,038,178 | 339,217 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $20,643,402 | 402,641 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,526,263 | 94,334 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,400,972 | 40,809 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,165,964 | 28,459 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $630,087 | 18,386 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||